NASDAQ:HRTX

Heron Therapeutics Stock Predictions

etoro logo Buy HRTX
*Your capital is at risk
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

HRTX Prediction Chart

HRTX Predictions History

Latest community submissions for HRTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 6, 2023 Bullish $2.52 X 0
Dec 28, 2022 Bearish $2.25 V 1
JS JS Pro
Nov 30, 2022 $2.56 -1.54% $2.70 X 94.81% 0
Nov 30, 2022 $2.70 +3.67% $2.70 V 99.83% 6
Nov 30, 2022 $2.66 +2.22% $2.70 V 98.43% 1
Nov 30, 2022 $2.68 -0.19% $2.70 X 99.07% 1
Nov 30, 2022 Bearish $2.70 X 0
JS JS Pro
Oct 10, 2022 $4.11 -1.91% $3.74 V 90.11% 1
Oct 10, 2022 $4.38 +4.57% $3.74 X 82.85% 0
Oct 10, 2022 $4.26 +1.57% $3.74 X 86.21% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HRTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT HERON THERAPEUTICS
Heron Therapeutics
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE